Autor: "Martinez-Sobrido, L" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Editorial for SARS-CoV-2 and COVID-19 Topical Collection.
Autorzy:: Martinez-Sobrido L; Texas Biomedical Research Institute, San Antonio, TX 78227, USA.
Almazán F; Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología (CNB), CSIC, 28049 Madrid, Spain.; Pokaż więcej
Źródło:: Viruses [Viruses] 2024 Feb 25; Vol. 16 (3). Date of Electronic Publication: 2024 Feb 25.
Typ publikacji:: Editorial
MeSH Terms:: COVID-19*
Animals ; Humans ; SARS-CoV-2 ; Animals, Wild ; China/epidemiology

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication in vivo.
Autorzy:: Taha TY; Gladstone Institute of Virology, Gladstone Institutes, San Francisco, California, United States of America.; Quantitative Biosciences Institute (QBI) COVID-19 Research Group (QCRG), San Francisco, California, United States of America.
Suryawanshi RK; Gladstone Institute of Virology, Gladstone Institutes, San Francisco, California, United States of America.; Quantitative Biosciences Institute (QBI) COVID-19 Research Group (QCRG), San Francisco, California, United States of America.
Chen IP; Gladstone Institute of Virology, Gladstone Institutes, San Francisco, California, United States of America.; Quantitative Biosciences Institute (QBI) COVID-19 Research Group (QCRG), San Francisco, California, United States of America.; Department of Medicine, University of California, San Francisco, California, United States of America.
Correy GJ; Quantitative Biosciences Institute (QBI) COVID-19 Research Group (QCRG), San Francisco, California, United States of America.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, California, United States of America.
McCavitt-Malvido M; Gladstone Institute of Virology, Gladstone Institutes, San Francisco, California, United States of America.; Quantitative Biosciences Institute (QBI) COVID-19 Research Group (QCRG), San Francisco, California, United States of America.
O'Leary PC; Quantitative Biosciences Institute (QBI) COVID-19 Research Group (QCRG), San Francisco, California, United States of America.; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States of America.
Jogalekar MP; Quantitative Biosciences Institute (QBI) COVID-19 Research Group (QCRG), San Francisco, California, United States of America.; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States of America.
Diolaiti ME; Quantitative Biosciences Institute (QBI) COVID-19 Research Group (QCRG), San Francisco, California, United States of America.; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States of America.
Kimmerly GR; Gladstone Institute of Virology, Gladstone Institutes, San Francisco, California, United States of America.
Tsou CL; Gladstone Institute of Virology, Gladstone Institutes, San Francisco, California, United States of America.
Gascon R; Gladstone Institute of Virology, Gladstone Institutes, San Francisco, California, United States of America.
Montano M; Gladstone Institute of Virology, Gladstone Institutes, San Francisco, California, United States of America.
Martinez-Sobrido L; Quantitative Biosciences Institute (QBI) COVID-19 Research Group (QCRG), San Francisco, California, United States of America.; Texas Biomedical Research Institute, San Antonio, Texas, United States of America.
Krogan NJ; Quantitative Biosciences Institute (QBI) COVID-19 Research Group (QCRG), San Francisco, California, United States of America.; Gladstone Institute of Data Science and Biotechnology, Gladstone Institutes, San Francisco, California, United States of America.; Quantitative Biosciences Institute (QBI), University of California, San Francisco, California, United States of America.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, California, United States of America.
Ashworth A; Quantitative Biosciences Institute (QBI) COVID-19 Research Group (QCRG), San Francisco, California, United States of America.; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States of America.
Fraser JS; Quantitative Biosciences Institute (QBI) COVID-19 Research Group (QCRG), San Francisco, California, United States of America.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, California, United States of America.
Ott M; Gladstone Institute of Virology, Gladstone Institutes, San Francisco, California, United States of America.; Quantitative Biosciences Institute (QBI) COVID-19 Research Group (QCRG), San Francisco, California, United States of America.; Department of Medicine, University of California, San Francisco, California, United States of America.; Chan Zuckerberg Biohub-San Francisco, San Francisco, California, United States of America.; Pokaż więcej
Źródło:: PLoS pathogens [PLoS Pathog] 2023 Aug 31; Vol. 19 (8), pp. e1011614. Date of Electronic Publication: 2023 Aug 31 (Print Publication: 2023).
Typ publikacji:: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: SARS-CoV-2*/genetics
SARS-CoV-2*/physiology
Virus Replication*
Coronavirus Papain-Like Proteases*/chemistry
Coronavirus Papain-Like Proteases*/genetics
Coronavirus Papain-Like Proteases*/metabolism
Animals ; Humans ; Mice ; Alanine ; Antiviral Agents

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Fc-Effector-Independent in vivo Activity of a Potent Influenza B Neuraminidase Broadly Neutralizing Antibody.
Autorzy:: Khalil AM; Texas Biomedical Research Institute, San Antonio, TX 78245, USA.; Department of Zoonotic Diseases, Faculty of Veterinary Medicine, Zagazig University, Zagazig 44511, Egypt.
Piepenbrink MS; Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Markham I; Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Basu M; Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Martinez-Sobrido L; Texas Biomedical Research Institute, San Antonio, TX 78245, USA.
Kobie JJ; Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL 35294, USA.; Pokaż więcej
Źródło:: Viruses [Viruses] 2023 Jul 13; Vol. 15 (7). Date of Electronic Publication: 2023 Jul 13.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:: Influenza, Human*
Influenza A virus*
Influenza Vaccines*
Orthomyxoviridae Infections*
Child ; Animals ; Mice ; Humans ; Broadly Neutralizing Antibodies ; Neuraminidase ; Antibodies, Viral ; Influenza B virus ; Antibodies, Monoclonal/pharmacology ; Receptors, Fc ; Hemagglutinin Glycoproteins, Influenza Virus

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Antibodies, B Cell Responses and Immune Responses to SARS-CoV-2 Infections.
Autorzy:: Martinez-Sobrido L; Texas Biomedical Research Institute, San Antonio, TX 78227, USA.
Kobie JJ; Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL 35294, USA.; Pokaż więcej
Źródło:: Antibodies (Basel, Switzerland) [Antibodies (Basel)] 2023 Feb 01; Vol. 12 (1). Date of Electronic Publication: 2023 Feb 01.
Typ publikacji:: Editorial

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Molecular Analyses of Clinical Isolates and Recombinant SARS-CoV-2 Carrying B.1 and B.1.617.2 Spike Mutations Suggest a Potential Role of Non-Spike Mutations in Infection Kinetics.
Autorzy:: Veleanu A; Institute for Medical Virology, University Hospital, Goethe University Frankfurt, D-60596 Frankfurt am Main, Germany.
Kelch MA; Institute for Medical Virology, University Hospital, Goethe University Frankfurt, D-60596 Frankfurt am Main, Germany.
Ye C; Texas Biomedical Research Institute, San Antonio, TX 78227-5302, USA.
Flohr M; Institute for Medical Virology, University Hospital, Goethe University Frankfurt, D-60596 Frankfurt am Main, Germany.
Wilhelm A; Institute for Medical Virology, University Hospital, Goethe University Frankfurt, D-60596 Frankfurt am Main, Germany.
Widera M; Institute for Medical Virology, University Hospital, Goethe University Frankfurt, D-60596 Frankfurt am Main, Germany.
Martinez-Sobrido L; Texas Biomedical Research Institute, San Antonio, TX 78227-5302, USA.
Ciesek S; Institute for Medical Virology, University Hospital, Goethe University Frankfurt, D-60596 Frankfurt am Main, Germany.; German Centre for Infection Research (DZIF), Partner Site Frankfurt am Main, D-60596 Frankfurt am Main, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor Stern Kai 7, D-60595 Frankfurt am Main, Germany.
Toptan T; Institute for Medical Virology, University Hospital, Goethe University Frankfurt, D-60596 Frankfurt am Main, Germany.; Pokaż więcej
Źródło:: Viruses [Viruses] 2022 Sep 12; Vol. 14 (9). Date of Electronic Publication: 2022 Sep 12.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:: COVID-19*
SARS-CoV-2*/genetics
Antibodies, Monoclonal ; Antibodies, Neutralizing ; Antibodies, Viral ; Glycoproteins/genetics ; Humans ; Mutation ; RNA, Complementary ; Spike Glycoprotein, Coronavirus
SCR Organism:: SARS-CoV-2 variants

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Effects of age, sex, serostatus, and underlying comorbidities on humoral response post-SARS-CoV-2 Pfizer-BioNTech mRNA vaccination: a systematic review.
Autorzy:: Notarte KI; Faculty of Medicine and Surgery, University of Santo Tomas, Manila, Philippines.
Ver AT; Faculty of Medicine and Surgery, University of Santo Tomas, Manila, Philippines.
Velasco JV; Faculty of Medicine and Surgery, University of Santo Tomas, Manila, Philippines.
Pastrana A; Faculty of Medicine and Surgery, University of Santo Tomas, Manila, Philippines.
Catahay JA; Faculty of Medicine and Surgery, University of Santo Tomas, Manila, Philippines.
Salvagno GL; Service of Laboratory Medicine, Pederzoli Hospital, Peschiera del Garda, Italy.; Section of Clinical Biochemistry, University of Verona, Verona, Italy.
Yap EPH; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
Martinez-Sobrido L; Disease Intervention & Prevention and Population Health Programs, Texas Biomedical Research Institute, San Antonio, TX, USA.
B Torrelles J; Disease Intervention & Prevention and Population Health Programs, Texas Biomedical Research Institute, San Antonio, TX, USA.
Lippi G; Section of Clinical Biochemistry, University of Verona, Verona, Italy.
Henry BM; Disease Intervention & Prevention and Population Health Programs, Texas Biomedical Research Institute, San Antonio, TX, USA.; Division of Nephrology and Hypertension, Clinical Laboratory, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.; Pokaż więcej
Źródło:: Critical reviews in clinical laboratory sciences [Crit Rev Clin Lab Sci] 2022 Sep; Vol. 59 (6), pp. 373-390. Date of Electronic Publication: 2022 Feb 28.
Typ publikacji:: Journal Article; Systematic Review
MeSH Terms:: COVID-19*/prevention & control
Viral Vaccines*
Aged ; Humans ; Male ; RNA, Messenger/genetics ; SARS-CoV-2 ; Vaccination

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Modeling SARS-CoV-2 and influenza infections and antiviral treatments in human lung epithelial tissue equivalents.
Autorzy:: Zarkoob H; 3D Tissue Bioprinting Lab, Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA.
Allué-Guardia A; Host-Pathogen Interactions and Population Health Programs, Texas Biomedical Research Institute, San Antonio, TX, USA.
Chen YC; 3D Tissue Bioprinting Lab, Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA.
Garcia-Vilanova A; Host-Pathogen Interactions and Population Health Programs, Texas Biomedical Research Institute, San Antonio, TX, USA.
Jung O; 3D Tissue Bioprinting Lab, Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA.; Biomedical Ultrasonics & Biotherapy Laboratory, Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Headington, UK.
Coon S; Molecular Genomics Core, National Institute of Child Health and Human Development, National Institutes of Health, Rockville, MD, USA.
Song MJ; 3D Tissue Bioprinting Lab, Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA.
Park JG; Host-Pathogen Interactions and Population Health Programs, Texas Biomedical Research Institute, San Antonio, TX, USA.
Oladunni F; Host-Pathogen Interactions and Population Health Programs, Texas Biomedical Research Institute, San Antonio, TX, USA.
Miller J; Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Microbiology, University of Pennsylvania, Philadelphia, PA, USA.
Tung YT; 3D Tissue Bioprinting Lab, Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA.
Kosik I; National Institute for Allergies and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Schultz D; Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA, USA.; High Throughput Screening Core, University of Pennsylvania, Philadelphia, PA, USA.
Iben J; Molecular Genomics Core, National Institute of Child Health and Human Development, National Institutes of Health, Rockville, MD, USA.
Li T; Molecular Genomics Core, National Institute of Child Health and Human Development, National Institutes of Health, Rockville, MD, USA.
Fu J; 3D Tissue Bioprinting Lab, Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA.
Porter FD; Section on Molecular Dysmorphology, Division of Translational Medicine, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, 20892, USA.
Yewdell J; National Institute for Allergies and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Martinez-Sobrido L; Host-Pathogen Interactions and Population Health Programs, Texas Biomedical Research Institute, San Antonio, TX, USA.
Cherry S; Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Microbiology, University of Pennsylvania, Philadelphia, PA, USA.
Torrelles JB; Host-Pathogen Interactions and Population Health Programs, Texas Biomedical Research Institute, San Antonio, TX, USA.
Ferrer M; 3D Tissue Bioprinting Lab, Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA. .
Lee EM; 3D Tissue Bioprinting Lab, Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA. .; Pokaż więcej
Źródło:: Communications biology [Commun Biol] 2022 Aug 12; Vol. 5 (1), pp. 810. Date of Electronic Publication: 2022 Aug 12.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Intramural
MeSH Terms:: Influenza A virus*/physiology
Influenza, Human*/drug therapy
COVID-19 Drug Treatment*
Antiviral Agents/pharmacology ; Antiviral Agents/therapeutic use ; Chemokines ; Epithelium ; Humans ; Lung ; SARS-CoV-2 ; Virus Replication

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody.
Autorzy:: Piepenbrink MS; Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Park JG; Texas Biomedical Research Institute, San Antonio, Texas, United States of America.
Deshpande A; Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Loos A; Aridis Pharmaceuticals Inc., Los Gatos, California, United States of America.
Ye C; Texas Biomedical Research Institute, San Antonio, Texas, United States of America.
Basu M; Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Sarkar S; Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Khalil AM; Texas Biomedical Research Institute, San Antonio, Texas, United States of America.
Chauvin D; Aridis Pharmaceuticals Inc., Los Gatos, California, United States of America.
Woo J; Aridis Pharmaceuticals Inc., Los Gatos, California, United States of America.
Lovalenti P; Aridis Pharmaceuticals Inc., Los Gatos, California, United States of America.
Erdmann NB; Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Goepfert PA; Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Truong VL; Aridis Pharmaceuticals Inc., Los Gatos, California, United States of America.
Bowen RA; Department of Biomedical Sciences, Colorado State University, Fort Collins, Colorado, United States of America.
Walter MR; Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Martinez-Sobrido L; Texas Biomedical Research Institute, San Antonio, Texas, United States of America.
Kobie JJ; Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.; Pokaż więcej
Źródło:: PLoS pathogens [PLoS Pathog] 2022 Jul 21; Vol. 18 (7), pp. e1010691. Date of Electronic Publication: 2022 Jul 21 (Print Publication: 2022).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:: COVID-19*/therapy
Spike Glycoprotein, Coronavirus*
Animals ; Antibodies, Monoclonal/pharmacology ; Antibodies, Neutralizing/pharmacology ; Antibodies, Viral ; COVID-19 Vaccines ; Humans ; Mice ; SARS-CoV-2 ; Weight Loss

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: 4'-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication.
Autorzy:: Sourimant J; Center for Translational Antiviral Research, Georgia State University, Atlanta, GA 30303, USA.
Lieber CM; Center for Translational Antiviral Research, Georgia State University, Atlanta, GA 30303, USA.
Aggarwal M; Center for Translational Antiviral Research, Georgia State University, Atlanta, GA 30303, USA.
Cox RM; Center for Translational Antiviral Research, Georgia State University, Atlanta, GA 30303, USA.
Wolf JD; Center for Translational Antiviral Research, Georgia State University, Atlanta, GA 30303, USA.
Yoon JJ; Center for Translational Antiviral Research, Georgia State University, Atlanta, GA 30303, USA.
Toots M; Center for Translational Antiviral Research, Georgia State University, Atlanta, GA 30303, USA.
Ye C; Texas Biomedical Research Institute, San Antonio, TX 78227, USA.
Sticher Z; Emory Institute for Drug Development, Emory University, Atlanta, GA 30322, USA.
Kolykhalov AA; Emory Institute for Drug Development, Emory University, Atlanta, GA 30322, USA.; Drug Innovation Ventures at Emory (DRIVE), Atlanta, GA 30322, USA.
Martinez-Sobrido L; Texas Biomedical Research Institute, San Antonio, TX 78227, USA.
Bluemling GR; Emory Institute for Drug Development, Emory University, Atlanta, GA 30322, USA.; Drug Innovation Ventures at Emory (DRIVE), Atlanta, GA 30322, USA.
Natchus MG; Emory Institute for Drug Development, Emory University, Atlanta, GA 30322, USA.
Painter GR; Emory Institute for Drug Development, Emory University, Atlanta, GA 30322, USA.; Drug Innovation Ventures at Emory (DRIVE), Atlanta, GA 30322, USA.; Department of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Plemper RK; Center for Translational Antiviral Research, Georgia State University, Atlanta, GA 30303, USA.; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.; Pokaż więcej
Źródło:: Science (New York, N.Y.) [Science] 2022 Jan 14; Vol. 375 (6577), pp. 161-167. Date of Electronic Publication: 2021 Dec 02.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:: COVID-19 Drug Treatment*
Antiviral Agents/*pharmacology
Respiratory Syncytial Virus Infections/*drug therapy
Respiratory Syncytial Virus, Human/*drug effects
SARS-CoV-2/*drug effects
Uracil Nucleotides/*pharmacology
Administration, Oral ; Animals ; Antiviral Agents/administration & dosage ; Antiviral Agents/metabolism ; COVID-19/virology ; Cell Line ; Coronavirus RNA-Dependent RNA Polymerase/metabolism ; Disease Models, Animal ; Female ; Ferrets ; Humans ; Mice ; Mice, Inbred BALB C ; Microbial Sensitivity Tests ; Mononegavirales/drug effects ; Mononegavirales/physiology ; RNA-Dependent RNA Polymerase/metabolism ; Respiratory Mucosa/virology ; Respiratory Syncytial Virus Infections/virology ; Respiratory Syncytial Virus, Human/genetics ; Respiratory Syncytial Virus, Human/physiology ; SARS-CoV-2/genetics ; SARS-CoV-2/physiology ; Transcription, Genetic ; Uracil Nucleotides/administration & dosage ; Uracil Nucleotides/metabolism ; Virus Replication/drug effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Long-term adaptation following influenza A virus host shifts results in increased within-host viral fitness due to higher replication rates, broader dissemination within the respiratory epithelium and reduced tissue damage.
Autorzy:: Amat JAR; MRC-University of Glasgow Centre for Virus Research, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom.; School of Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom.
Patton V; School of Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom.
Chauché C; MRC-University of Glasgow Centre for Virus Research, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom.; Centre for Inflammation Research, University of Edinburgh, The Queen's Medical Research Institute, Edinburgh, Scotland, United Kingdom.
Goldfarb D; MRC-University of Glasgow Centre for Virus Research, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom.
Crispell J; MRC-University of Glasgow Centre for Virus Research, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom.
Gu Q; MRC-University of Glasgow Centre for Virus Research, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom.
Coburn AM; MRC-University of Glasgow Centre for Virus Research, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom.
Gonzalez G; MRC-University of Glasgow Centre for Virus Research, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom.; Ecole Nationale Vétérinaire d'Alfort, Université Paris-Est, Maisons-Alfort, France.
Mair D; MRC-University of Glasgow Centre for Virus Research, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom.
Tong L; MRC-University of Glasgow Centre for Virus Research, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom.
Martinez-Sobrido L; Texas Biomedical Research Institute, San Antonio, Texas, United States of America.
Marshall JF; School of Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom.
Marchesi F; School of Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom.
Murcia PR; MRC-University of Glasgow Centre for Virus Research, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom.; Pokaż więcej
Źródło:: PLoS pathogens [PLoS Pathog] 2021 Dec 17; Vol. 17 (12), pp. e1010174. Date of Electronic Publication: 2021 Dec 17 (Print Publication: 2021).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Adaptation, Physiological/*physiology
Host-Pathogen Interactions/*physiology
Influenza A Virus, H3N8 Subtype/*pathogenicity
Influenza A Virus, H3N8 Subtype/*physiology
Orthomyxoviridae Infections/*virology
Animals ; Genetic Fitness/physiology ; Horses

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Natural Selection of H5N1 Avian Influenza A Viruses with Increased PA-X and NS1 Shutoff Activity.
Autorzy:: Nogales A; Center for Animal Health Research, CISA-INIA-CSIC, Valdeolmos, 28130 Madrid, Spain.
Villamayor L; Department of Molecular and Cell Biology, Centro Nacional de Biotecnología (CNB-CSIC), Campus Universidad Autónoma de Madrid, 28049 Madrid, Spain.
Utrilla-Trigo S; Center for Animal Health Research, CISA-INIA-CSIC, Valdeolmos, 28130 Madrid, Spain.
Ortego J; Center for Animal Health Research, CISA-INIA-CSIC, Valdeolmos, 28130 Madrid, Spain.
Martinez-Sobrido L; Department of Disease Intervention and Prevention, Texas Biomedical Research Institute, San Antonio, TX 78227, USA.
DeDiego ML; Department of Molecular and Cell Biology, Centro Nacional de Biotecnología (CNB-CSIC), Campus Universidad Autónoma de Madrid, 28049 Madrid, Spain.; Pokaż więcej
Źródło:: Viruses [Viruses] 2021 Sep 03; Vol. 13 (9). Date of Electronic Publication: 2021 Sep 03.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Selection, Genetic*
Influenza A Virus, H5N1 Subtype/*genetics
Repressor Proteins/*metabolism
Viral Nonstructural Proteins/*metabolism
Animals ; Birds ; Female ; HEK293 Cells ; Host-Pathogen Interactions/immunology ; Humans ; Immunity, Innate ; Influenza A virus/genetics ; Influenza in Birds ; Influenza, Human/virology ; Interferons/metabolism ; Male ; Mice ; Orthomyxoviridae Infections/virology ; Repressor Proteins/genetics ; Viral Nonstructural Proteins/genetics ; Virulence ; Virus Replication/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Equine Influenza Virus and Vaccines.
Autorzy:: Oladunni FS; Texas Biomedical Research Institute, San Antonio, TX 78245, USA.; Department of Veterinary Microbiology, University of Ilorin, Ilorin P.M.B. 1515, Nigeria.
Oseni SO; Department of Biological Sciences, Florida Atlantic University, Davie, FL 33431, USA.
Martinez-Sobrido L; Texas Biomedical Research Institute, San Antonio, TX 78245, USA.
Chambers TM; Department of Veterinary Science, Gluck Equine Research Center, University of Kentucky, Lexington, KY 40546, USA.; Pokaż więcej
Źródło:: Viruses [Viruses] 2021 Aug 20; Vol. 13 (8). Date of Electronic Publication: 2021 Aug 20.
Typ publikacji:: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Review
MeSH Terms:: Horse Diseases/*prevention & control
Influenza A Virus, H3N8 Subtype/*immunology
Influenza A Virus, H7N7 Subtype/*immunology
Influenza Vaccines/*immunology
Orthomyxoviridae Infections/*veterinary
Animals ; Antibodies, Viral/immunology ; Horse Diseases/immunology ; Horse Diseases/virology ; Horses ; Influenza A Virus, H3N8 Subtype/genetics ; Influenza A Virus, H3N8 Subtype/physiology ; Influenza A Virus, H7N7 Subtype/genetics ; Influenza A Virus, H7N7 Subtype/physiology ; Influenza Vaccines/administration & dosage ; Orthomyxoviridae Infections/immunology ; Orthomyxoviridae Infections/prevention & control ; Orthomyxoviridae Infections/virology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Replication-Competent ΔNS1 Influenza A Viruses Expressing Reporter Genes.
Autorzy:: Nogales A; Animal Health Research Centre (CISA), National Institute for Agriculture and Food Research and Technology (INIA), Valdeolmos, 28130 Madrid, Spain.
Schotsaert M; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Rathnasinghe R; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
DeDiego ML; Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas, 28049 Madrid, Spain.
García-Sastre A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Martinez-Sobrido L; Texas Biomedical Research Institute, San Antonio, TX 78227, USA.; Pokaż więcej
Źródło:: Viruses [Viruses] 2021 Apr 17; Vol. 13 (4). Date of Electronic Publication: 2021 Apr 17.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Influenza A virus/*physiology
Influenza, Human/*virology
Orthomyxoviridae Infections/*virology
Viral Nonstructural Proteins/*metabolism
Animals ; Dogs ; Genes, Reporter ; HEK293 Cells ; Humans ; Influenza A virus/genetics ; Madin Darby Canine Kidney Cells ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Viral Nonstructural Proteins/genetics ; Virus Replication

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Identification of Inhibitors of ZIKV Replication.
Autorzy:: Morales Vasquez D; Clinical and Translational Science Institute, University of Rochester School of Medicine and Dentistry, Rochester, New York, NY 14625, USA.; Department of Microbiology and Immunology, University of Rochester, Rochester, New York, NY 14625, USA.; Department of Disease Intervention and Prevention, Texas Biomedical Research Institute, San Antonio, TX 78227, USA.
Park JG; Department of Microbiology and Immunology, University of Rochester, Rochester, New York, NY 14625, USA.; Department of Disease Intervention and Prevention, Texas Biomedical Research Institute, San Antonio, TX 78227, USA.
Ávila-Pérez G; Department of Microbiology and Immunology, University of Rochester, Rochester, New York, NY 14625, USA.
Nogales A; Department of Microbiology and Immunology, University of Rochester, Rochester, New York, NY 14625, USA.
de la Torre JC; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Almazan F; Department of Molecular and Cell Biology, Centro Nacional de Biotecnología (CNB-11 CSIC), Universidad Autonόma de Madrid, 28049 Madrid, Spain.
Martinez-Sobrido L; Department of Microbiology and Immunology, University of Rochester, Rochester, New York, NY 14625, USA.; Department of Disease Intervention and Prevention, Texas Biomedical Research Institute, San Antonio, TX 78227, USA.; Pokaż więcej
Źródło:: Viruses [Viruses] 2020 Sep 18; Vol. 12 (9). Date of Electronic Publication: 2020 Sep 18.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:: Antiviral Agents/*pharmacology
Virus Replication/*drug effects
Zika Virus/*drug effects
A549 Cells ; Animals ; Antiviral Agents/chemistry ; Apoptosis/drug effects ; Azauridine/analogs & derivatives ; Azauridine/pharmacology ; Biphenyl Compounds/pharmacology ; Carbamates/pharmacology ; Cell Survival/drug effects ; Chlorocebus aethiops ; Drug Repositioning ; Guillain-Barre Syndrome ; Humans ; Microcephaly ; Phenylurea Compounds/pharmacology ; Uganda ; Vero Cells ; Zika Virus Infection/drug therapy ; Zika Virus Infection/virology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Characterizing Emerging Canine H3 Influenza Viruses.
Autorzy:: Martinez-Sobrido L; Department of Microbiology and Immunology, University of Rochester, Rochester, New York, United States of America.
Blanco-Lobo P; Department of Microbiology and Immunology, University of Rochester, Rochester, New York, United States of America.
Rodriguez L; Department of Microbiology and Immunology, University of Rochester, Rochester, New York, United States of America.
Fitzgerald T; David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, New York, United States of America.
Zhang H; Department of Dermatology, University of Rochester, Rochester, New York, United States of America.; Materials Science Program, University of Rochester, Rochester, New York, United States of America.
Nguyen P; David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, New York, United States of America.
Anderson CS; David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, New York, United States of America.
Holden-Wiltse J; Department of Biostatistics and Computational Biology and Clinical and Translational Science Institute, University of Rochester, Rochester, New York, United States of America.
Bandyopadhyay S; Department of Biostatistics and Computational Biology and Clinical and Translational Science Institute, University of Rochester, Rochester, New York, United States of America.
Nogales A; Department of Microbiology and Immunology, University of Rochester, Rochester, New York, United States of America.
DeDiego ML; David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, New York, United States of America.
Wasik BR; Baker Institute for Animal Health, Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, New York, United States of America.
Miller BL; Department of Dermatology, University of Rochester, Rochester, New York, United States of America.; Materials Science Program, University of Rochester, Rochester, New York, United States of America.
Henry C; The Department of Medicine, Section of Rheumatology, The Knapp Center for Lupus and Immunology Research, The University of Chicago, Chicago, Illinois, United States of America.
Wilson PC; The Department of Medicine, Section of Rheumatology, The Knapp Center for Lupus and Immunology Research, The University of Chicago, Chicago, Illinois, United States of America.
Sangster MY; David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, New York, United States of America.
Treanor JJ; David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, New York, United States of America.
Topham DJ; David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, New York, United States of America.
Byrd-Leotis L; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, United States of America.; Beth Israel Deaconess Medical Center, Department of Surgery and Harvard Medical School Center for Glycoscience, Harvard Medical School, Boston, Massachusetts, United States of America.
Steinhauer DA; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Cummings RD; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, United States of America.; Beth Israel Deaconess Medical Center, Department of Surgery and Harvard Medical School Center for Glycoscience, Harvard Medical School, Boston, Massachusetts, United States of America.
Luczo JM; Center for Vaccines and Immunology, University of Georgia, Athens, Georgia, United States of America.
Tompkins SM; Center for Vaccines and Immunology, University of Georgia, Athens, Georgia, United States of America.
Sakamoto K; Department of Pathology, University of Georgia, Athens, Georgia, United States of America.
Jones CA; Center for Vaccines and Immunology, University of Georgia, Athens, Georgia, United States of America.
Steel J; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Lowen AC; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Danzy S; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Tao H; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Fink AL; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Klein SL; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Wohlgemuth N; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Fenstermacher KJ; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
El Najjar F; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Pekosz A; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Sauer L; Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Lewis MK; Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Shaw-Saliba K; Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Rothman RE; Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Liu ZY; Department of Emergency Medicine, Chang Gung Memorial Hospital, Taiwan.
Chen KF; Department of Emergency Medicine, Chang Gung Memorial Hospital, Taiwan.
Parrish CR; Baker Institute for Animal Health, Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, New York, United States of America.
Voorhees IEH; Baker Institute for Animal Health, Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, New York, United States of America.
Kawaoka Y; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison. Madison, Wisconsin, United States of America.
Neumann G; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison. Madison, Wisconsin, United States of America.
Chiba S; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison. Madison, Wisconsin, United States of America.
Fan S; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison. Madison, Wisconsin, United States of America.
Hatta M; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison. Madison, Wisconsin, United States of America.
Kong H; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison. Madison, Wisconsin, United States of America.
Zhong G; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison. Madison, Wisconsin, United States of America.
Wang G; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Uccellini MB; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
García-Sastre A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Perez DR; Department of Population Health, University of Georgia, Athens, Georgia, United States of America.
Ferreri LM; Department of Population Health, University of Georgia, Athens, Georgia, United States of America.
Herfst S; Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands.
Richard M; Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands.
Fouchier R; Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands.
Burke D; Center for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge, United Kingdom.
Pattinson D; Center for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge, United Kingdom.
Smith DJ; Center for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge, United Kingdom.
Meliopoulos V; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
Freiden P; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
Livingston B; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
Sharp B; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
Cherry S; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
Dib JC; Tropical Health Foundation, Santa Marta, Magdalena, Colombia.
Yang G; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
Russell CJ; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
Barman S; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
Webby RJ; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
Krauss S; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
Danner A; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
Woodard K; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
Peiris M; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, Republic of China.
Perera RAPM; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, Republic of China.
Chan MCW; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, Republic of China.
Govorkova EA; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
Marathe BM; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
Pascua PNQ; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
Smith G; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
Li YT; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
Thomas PG; Department of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
Schultz-Cherry S; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.; Pokaż więcej
Źródło:: PLoS pathogens [PLoS Pathog] 2020 Apr 14; Vol. 16 (4), pp. e1008409. Date of Electronic Publication: 2020 Apr 14 (Print Publication: 2020).
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:: Communicable Diseases, Emerging/*veterinary
Dog Diseases/*virology
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza A Virus, H3N8 Subtype/*isolation & purification
Influenza A virus/*isolation & purification
Zoonoses/*virology
Animals ; Communicable Diseases, Emerging/transmission ; Communicable Diseases, Emerging/virology ; Dog Diseases/transmission ; Dogs ; Ferrets ; Guinea Pigs ; Humans ; Influenza A Virus, H3N2 Subtype/classification ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza A Virus, H3N8 Subtype/classification ; Influenza A Virus, H3N8 Subtype/genetics ; Influenza A virus/classification ; Influenza A virus/genetics ; Influenza, Human/transmission ; Influenza, Human/virology ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Mice, Inbred DBA ; United States ; Zoonoses/transmission

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Differences in Tissue and Species Tropism of Reptarenavirus Species Studied by Vesicular Stomatitis Virus Pseudotypes.
Autorzy:: Korzyukov Y; Medicum, Department of Virology, University of Helsinki, 00100 Helsinki, Finland.
Iheozor-Ejiofor R; Medicum, Department of Virology, University of Helsinki, 00100 Helsinki, Finland.
Levanov L; Medicum, Department of Virology, University of Helsinki, 00100 Helsinki, Finland.
Smura T; Medicum, Department of Virology, University of Helsinki, 00100 Helsinki, Finland.
Hetzel U; Vetsuisse Faculty, Institute of Veterinary Pathology, University of Zürich, 8006 Zürich, Switzerland.; Department of Veterinary Biosciences, Faculty of Veterinary Medicine, University of Helsinki, 00100 Helsinki, Finland.
Szirovicza L; Medicum, Department of Virology, University of Helsinki, 00100 Helsinki, Finland.
de la Torre JC; Department of Immunology and Microbial Science IMM-6, The Scripps Research Institute, La Jolla, CA 92037, USA.
Martinez-Sobrido L; Texas Biomedical Research Institute, San Antonio, TX 78227, USA.
Kipar A; Vetsuisse Faculty, Institute of Veterinary Pathology, University of Zürich, 8006 Zürich, Switzerland.; Department of Veterinary Biosciences, Faculty of Veterinary Medicine, University of Helsinki, 00100 Helsinki, Finland.
Vapalahti O; Medicum, Department of Virology, University of Helsinki, 00100 Helsinki, Finland.; Department of Veterinary Biosciences, Faculty of Veterinary Medicine, University of Helsinki, 00100 Helsinki, Finland.; Department of Virology, Helsinki University Hospital, University of Helsinki, 00100 Helsinki, Finland.
Hepojoki J; Medicum, Department of Virology, University of Helsinki, 00100 Helsinki, Finland.; Vetsuisse Faculty, Institute of Veterinary Pathology, University of Zürich, 8006 Zürich, Switzerland.; Pokaż więcej
Źródło:: Viruses [Viruses] 2020 Apr 02; Vol. 12 (4). Date of Electronic Publication: 2020 Apr 02.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Viral Envelope Proteins*/genetics
Viral Envelope Proteins*/metabolism
Viral Tropism*
Arenaviridae/*physiology
Vesiculovirus/*physiology
A549 Cells ; Animals ; Arenaviridae/genetics ; Cell Line ; Chlorocebus aethiops ; Green Fluorescent Proteins/genetics ; HEK293 Cells ; Humans ; Snakes ; Vero Cells ; Vesiculovirus/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: A Broad and Potent H1-Specific Human Monoclonal Antibody Produced in Plants Prevents Influenza Virus Infection and Transmission in Guinea Pigs.
Autorzy:: Park JG; Department of Microbiology and Immunology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA.
Ye C; Department of Microbiology and Immunology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA.
Piepenbrink MS; Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham 845 19th Street South, Birmingham, AL 35294, USA.
Nogales A; Department of Microbiology and Immunology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA.; Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria, Centro de Investigación en Sanidad Animal (INIA-CISA), 28130 Madrid, Spain.
Wang H; PlantForm Corporation, 1920 Yonge St., Suite 200, Toronto, ON M4S 3E2, Canada.
Shuen M; PlantForm Corporation, 1920 Yonge St., Suite 200, Toronto, ON M4S 3E2, Canada.
Meyers AJ; AntoXa Corporation, 1920 Yonge St., Suite 200, Toronto, ON M4S 3E2, Canada.
Martinez-Sobrido L; Department of Microbiology and Immunology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA.
Kobie JJ; Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham 845 19th Street South, Birmingham, AL 35294, USA.; Pokaż więcej
Źródło:: Viruses [Viruses] 2020 Feb 02; Vol. 12 (2). Date of Electronic Publication: 2020 Feb 02.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Antibodies, Monoclonal/*therapeutic use
Antibodies, Viral/*therapeutic use
Influenza A Virus, H1N1 Subtype/*immunology
Orthomyxoviridae Infections/*prevention & control
Orthomyxoviridae Infections/*transmission
Plantibodies/*therapeutic use
Animals ; Antibodies, Monoclonal/biosynthesis ; Antibodies, Viral/biosynthesis ; Female ; Guinea Pigs ; Orthomyxoviridae Infections/therapy ; Nicotiana/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: A Bivalent Live-Attenuated Vaccine for the Prevention of Equine Influenza Virus.
Autorzy:: Blanco-Lobo P; Department of Microbiology and Immunology, University of Rochester, Rochester, NY 14642, USA. .
Rodriguez L; Department of Microbiology and Immunology, University of Rochester, Rochester, NY 14642, USA. .; Agencia Española de Medicamentos y Productos Sanitarios, E28022 Madrid, Spain. .
Reedy S; Department of Veterinary Science, Gluck Equine Research Center, University of Kentucky, Lexington, KY 40546, USA. .
Oladunni FS; Department of Veterinary Science, Gluck Equine Research Center, University of Kentucky, Lexington, KY 40546, USA. .
Nogales A; Department of Microbiology and Immunology, University of Rochester, Rochester, NY 14642, USA. .; Center for Animal Health Research- National Institute for Agricultural and Food Research and Technology, Valdeolmos, 28130 Madrid, Spain. .
Murcia PR; MRC-University of Glasgow Centre for Virus Research, Glasgow G61 1AF, UK. .
Chambers TM; Department of Veterinary Science, Gluck Equine Research Center, University of Kentucky, Lexington, KY 40546, USA. .
Martinez-Sobrido L; Department of Microbiology and Immunology, University of Rochester, Rochester, NY 14642, USA. luis_martinez@urmc.rochester.edu.; Pokaż więcej
Źródło:: Viruses [Viruses] 2019 Oct 11; Vol. 11 (10). Date of Electronic Publication: 2019 Oct 11.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Influenza Vaccines*
Vaccines, Synthetic*
Influenza A Virus, H3N8 Subtype/*immunology
Vaccination/*veterinary
Animals ; Horse Diseases/virology ; Horses ; Humans ; Influenza, Human/prevention & control ; Reverse Genetics/methods ; Reverse Genetics/veterinary ; Vaccines, Attenuated

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: New Advances on Zika Virus Research.
Autorzy:: Martinez-Sobrido L; Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA. Luis_Martinez@URMC.Rochester.edu.
Almazán F; Department of Molecular and Cell Biology, Centro Nacional de Biotecnología (CNB-CSIC), Campus Universidad Autónoma de Madrid, 3 Darwin street, 28049 Madrid, Spain. .; Pokaż więcej
Źródło:: Viruses [Viruses] 2019 Mar 14; Vol. 11 (3). Date of Electronic Publication: 2019 Mar 14.
Typ publikacji:: Editorial; Introductory Journal Article
MeSH Terms:: Host Microbial Interactions*
Research/*trends
Zika Virus Infection/*epidemiology
Disease Outbreaks ; Female ; Humans ; Mosquito Vectors/virology ; Pregnancy ; Pregnancy Complications, Infectious/virology ; Zika Virus/pathogenicity ; Zika Virus Infection/complications

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Modulation of Innate Immune Responses by the Influenza A NS1 and PA-X Proteins.
Autorzy:: Nogales A; Department of Microbiology and Immunology, University of Rochester, Rochester, New York, NY 14642, USA. Aitor_.; Centro de Investigación en Sanidad Animal (CISA)-INIA, Valdeolmos, 28130 Madrid, Spain. Aitor_.
Martinez-Sobrido L; Department of Microbiology and Immunology, University of Rochester, Rochester, New York, NY 14642, USA. Luis_martinez@urmc.rochester.edu.
Topham DJ; Department of Microbiology and Immunology, University of Rochester, Rochester, New York, NY 14642, USA. David_.; David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, New York, NY 14642, USA. David_.
DeDiego ML; Department of Microbiology and Immunology, University of Rochester, Rochester, New York, NY 14642, USA. .; David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, New York, NY 14642, USA. .; Department of Molecular and Cell Biology, Centro Nacional de Biotecnología (CNB-CSIC), Campus Universidad Autónoma de Madrid, 28049 Madrid, Spain. .; Pokaż więcej
Źródło:: Viruses [Viruses] 2018 Dec 12; Vol. 10 (12). Date of Electronic Publication: 2018 Dec 12.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Review
MeSH Terms:: Immunity, Innate*
Host-Pathogen Interactions/*immunology
Influenza A virus/*immunology
Repressor Proteins/*immunology
Viral Nonstructural Proteins/*immunology
Animals ; Humans ; Immune Evasion ; Influenza A virus/pathogenicity ; Influenza, Human/immunology ; Interferons/immunology ; Mice ; Orthomyxoviridae Infections/immunology ; Virulence ; Virus Replication

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Martinez-Sobrido, L"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język